Introduction Semaglutide Has emerged as a groundbreaking medication in the treatment of type 2 diabetes and obesity, with its ability to address multiple health issues through a single solution. Initially developed as a therapy for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonists, a class of drugs that https://juliusrkbnx.thenerdsblog.com/37238042/semaglutide-revolutionizing-diabetes-management-and-weight-loss